Bifurcation analysis of a tuberculosis progression model for drug target identification
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Bifurcation analysis of a tuberculosis progression model for drug target identification ; volume:13 ; number:1 ; day:16 ; month:10 ; year:2023 ; pages:1-15 ; date:12.2023
Scientific reports ; 13, Heft 1 (16.10.2023), 1-15, 12.2023
- Creator
-
Flores-Garza, Eliezer
Hernández-Pando, Rogelio
García-Zárate, Ibrahim
Aguirre, Pablo
Domínguez-Hüttinger, Elisa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44569-7
- URN
-
urn:nbn:de:101:1-2024020512153230716802
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Flores-Garza, Eliezer
- Hernández-Pando, Rogelio
- García-Zárate, Ibrahim
- Aguirre, Pablo
- Domínguez-Hüttinger, Elisa
- SpringerLink (Online service)
Other Objects (12)
Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Drug-drug relationship based on target information: application to drug target identification
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis : biochemical and immunological characterization
Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
The “funitel” technique for endoscopic target biopsy at a biliary bifurcation
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Drug-drug relationship based on target information: application to drug target identification
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis : biochemical and immunological characterization
Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
The “funitel” technique for endoscopic target biopsy at a biliary bifurcation
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Drug-drug relationship based on target information: application to drug target identification
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis : biochemical and immunological characterization
Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
The “funitel” technique for endoscopic target biopsy at a biliary bifurcation
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis